Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group

Main Article Content

Amir Shamshirian
Reza Alizadeh-Navaei
Samira Abedi
Hamed Jafarpour
Hanieh Fazli
Samira Hosseini
Amirhossein Hessami
Keyvan Karimifar
Sedighe Yosefi
Mohammad Zahedi
Sepideh Motamen
Atiyeh Ghorbanpour
Bahman Zarandi
Aliakbar Esfahani
Yeganeh Rostamian-Moghaddam
Shirin Mehdipour
Keyvan Heydari
Sedigheh Aghajanian
Somayeh Pour Mehdi
Alireza Azad
Soheil Azizi

Abstract

BACKGROUND: Myocardial infarction (MI) as a term for aheart attack happens due to reduced blood flow to heartmyocardium and lack of oxygen supply caused by plaques inthe interior walls of coronary arteries. With respect to theimportance of MI etiology, we aimed to study the relationshipof MI and blood examination variables.


METHODS: This study was conducted in Mazandaran HeartCenter as a hospital-based case-control Comprising 894participants including 465 cases and 429 controls,individually matched by sex and age. Considered bloodmarkers were analyzed using routine laboratory methods andequipment.


RESULTS: Of all participants, 64.3% of the cases and 51.0%of the controls were males with a mean age of 61.2 (±13.8) incases and 62.4 (±14.) in controls. We could not find anydifferences between cases and controls for total cholesterol(TC), low-density lipoprotein (LDL), high-density lipoprotein(HDL), and alkaline-phosphatase (ALP) (P>0.05). However,levels of creatine-kinase-muscle/brain (CK-MB) (P<0.0001),fasting-blood-sugar(FBS)(P<0.0001),aspartate-aminotransferase (AST) (P<0.0001), alanine-transferase(ALT) (P<0.0001) and erythrocyte sedimentation rate (ESR)(P=0.001) were significantly higher in cases compared to thecontrols (P<0.05). Multivariable analyses revealed that therisk of MI was associated with high levels of AST (adjustedOR=24.3, 95%CI=3.5±165.6, P=0.001) and LDL (adjustedOR=7.4, 95%CI=1.0±51.8, P=0.001).


CONCLUSION: Our investigation indicated that the levels ofCK-MB, FBS, AST, ALT and ESR were significantly higherin patients with MI. Besides, our findings showed that therisk of MI in cases with high levels of AST and LDL wasabout 24 and 7 times more than the control grouprespectively.

Article Details

Section
Original Article
Author Biographies

Amir Shamshirian, Mazandaran University of Medical Sciences,

Department of Medical Laboratory Sciences,
School of Allied Medical sciences, Mazandaran
University of Medical Sciences, Iran.

Gastrointestinal Cancer Research Center,
Mazandaran University of Medical Sciences, Iran.

Mazandaran
Heart
Center,
Mazandaran
University of Medical Sciences, Iran.

Reza Alizadeh-Navaei, Mazandaran University of Medical Sciences, Iran.

Gastrointestinal Cancer Research Center,
Mazandaran University of Medical Sciences, Iran.

Samira Abedi, Mazandaran University of Medical Sciences

Student Research Committee, School of
Medicine, Mazandaran University of Medical
Sciences, Iran

Hamed Jafarpour, Mazandaran University of Medical Sciences

Student Research Committee, School of
Medicine, Mazandaran University of Medical
Sciences, Iran.

Hanieh Fazli, Mazandaran University of Medical Sciences

Student Research Committee, School of
Medicine, Mazandaran University of Medical
Sciences, Iran

Samira Hosseini, Mazandaran University of Medical Sciences

Department of Medical Laboratory Sciences,
School of Allied Medical sciences, Mazandaran
University of Medical Sciences, Iran.

Amirhossein Hessami, Mazandaran University of Medical Sciences

Student Research Committee, School of
Medicine, Mazandaran University of Medical
Sciences, Iran.

Keyvan Karimifar, Mashhad University of Medical Sciences

tudent Research committee, Mashhad University of Medical Sciences, Mashhad, Iran.

Sedighe Yosefi, Semnan University of MedicalSciences

Department of Biochemistry, Faculty of
Medicine, Semnan University of Medical
Sciences, Semnan, Iran.

Mohammad Zahedi, Semnan University of MedicalSciences

Department of Medical Laboratory Sciences,
School of Allied Medical sciences, Mazandaran
University of Medical Sciences, Iran.

Sepideh Motamen, Tarbiat Modares University

Department of Medical Biotechnology, Faculty
of Medical Sciences, Tarbiat Modares University,
Iran.

Atiyeh Ghorbanpour, Iran University of Medical Sciences, Iran.

Department of Hematology, Student Research
Committee, Iran University of Medical Sciences,
Iran.

Bahman Zarandi, Iran University of Medical Sciences

Department of Hematology, Student Research
Committee, Iran University of Medical Sciences,
Iran.

Aliakbar Esfahani, Mashhad University of Medical Sciences

Student
Research
committee,
Mashhad
University of Medical Sciences, Mashhad, Iran.

Yeganeh Rostamian-Moghaddam, Mazandaran Blood Transfusion Center

Blood Transfusion Research Center, Mazandaran
Blood Transfusion Center, Sari, Iran

Shirin Mehdipour, Mazandaran University of Medical Sciences

Mazandaran
Heart
Center,
Mazandaran
University of Medical Sciences, Iran.

Keyvan Heydari, Mazandaran University of Medical Sciences

Student Research Committee, School of
Medicine, Mazandaran University of Medical
Sciences, Iran.

Sedigheh Aghajanian, Mazandaran University of Medical Sciences

Department of Medical Laboratory Sciences,
School of Allied Medical sciences, Mazandaran
University of Medical Sciences, Iran.

Somayeh Pour Mehdi, Mazandaran University of Medical Sciences

Mazandaran Heart Center, Mazandaran University of Medical Sciences, Iran.

Alireza Azad , Mazandaran University of Medical Sciences

Mazandaran Heart Center, Mazandaran University of Medical Sciences, Iran.

Soheil Azizi, Mazandaran University of Medical Sciences

Department of Medical Laboratory Sciences, School of Allied Medical sciences, Mazandaran University of Medical  Sciences, Iran.

Mazandaran Heart Center, Mazandaran University of Medical Sciences, Iran.